190 related articles for article (PubMed ID: 8383394)
1. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number.
Cordier-Bussat M; Calender A; Vuillaume M; Bornkamm GW; Lenoir GM
Virus Res; 1993 Jan; 27(1):55-69. PubMed ID: 8383394
[TBL] [Abstract][Full Text] [Related]
2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
[TBL] [Abstract][Full Text] [Related]
4. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
7. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
10. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
[TBL] [Abstract][Full Text] [Related]
11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
Cordier-Bussat M; Billaud M; Calender A; Lenoir GM
Int J Cancer; 1993 Jan; 53(1):153-60. PubMed ID: 8416201
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
15. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
16. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
Gahn TA; Sugden B
J Virol; 1993 Nov; 67(11):6379-86. PubMed ID: 8411339
[TBL] [Abstract][Full Text] [Related]
17. Infection of leukaemic B lymphocytes by Epstein Barr virus.
Doyle MG; Catovsky D; Crawford DH
Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
[TBL] [Abstract][Full Text] [Related]
18. [The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].
Borisch B; Telenti A; Hennig I; Marchesi F; Audouin J; Diebold J; Pallesen G
Verh Dtsch Ges Pathol; 1992; 76():181-4. PubMed ID: 1336913
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
